Dr. Narongsack
ActiveDr. Narongsack has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3k and a net result of €110k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
68
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency26▼-74
Growth58▼-20
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
1.1%
Return on assets
38.7%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 16491 sector peers (2025).
NBB · sector comparisonPosition among 16491 sector peers
Solvency
better than 5%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
28 d early
2024
20 d early
2023
6 d early
2022
27 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€3k▼ 99.1%
2024 · €345k
2022: €111k
2023: €218k
2024: €345k
2022 → 2025
Total assets
€283k▼ 33.3%
2024 · €425k
2022: €145k
2023: €329k
2024: €425k
2022 → 2025
Net result
€110k▼ 14.0%
2024 · €128k
2022: €108k
2023: €106k
2024: €128k
2022 → 2025
Working capital
€-9k
2024 · €332k
2022: €97k
2023: €200k
2024: €332k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€111k-€218k▲ 95.6%€345k▲ 58.6%€3k▼ 99.1%
Operating result€138k-€132k▼ 3.7%€156k▲ 18.1%€138k▼ 11.5%
Net result€108k-€106k▼ 1.8%€128k▲ 19.9%€110k▼ 14.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 11% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €283k
Fixed assets
€31k▼ 26.6%
Current assets
€253k▼ 34.0%
Equity and liabilities €283k
Equity
€3k▼ 99.1%
Debt
€280k▲ 254%
The debt ratio rises from 18.7% to 98.9%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€151k▼
2024 · €170k
Cash flow
€122k▼
2024 · €141k
Solvency
1.1%▼
2024 · 81.3%
Current ratio
0.96▼
2024 · 7.48
Quick ratio
0.96▼
2024 · 7.48
Debt / equity
93.44▲
2024 · 0.23
ROA
38.7%▲
2024 · 30.0%
Interest coverage
36.07▼
2024 · 56.66
Debt
€280k▲
2024 · €79k
Debt ≤ 1 year
€262k▲
2024 · €51k
Debt > 1 year
€18k▼
2024 · €28k
Income taxes
€34k▼
2024 · €38k
A ratio outside any meaningful range has been withheld (balance sheet total €283k, equity €3k).
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€425k€283k▼
Fixed assets21/28€42k€31k▼
Tangible fixed assets22/27€42k€31k▼
Plant, machinery and equipment23€3k€2k▼
Furniture and vehicles24€39k€29k▼
Current assets29/58€383k€253k▼
Amounts receivable after more than one year29€76k€0▼
Other amounts receivable291€76k€0▼
Amounts receivable within one year40/41€172k€119k▼
Trade receivables40-€2k
Other amounts receivable41€172k€116k▼
Current investments50/53€69k€10k▼
Cash at bank and in hand54/58€62k€123k▲
Deferred charges and accrued income490/1€3k€2k▼
Equity and liabilities
Total equity and liabilities10/49€425k€283k▼
Equity10/15€345k€3k▼
Contributions10/11€3k€3k=
Reserves13€342k€0▼
Distributable reserves133€342k€0▼
Profit (loss) carried forward14-€0
Amounts payable17/49€79k€280k▲
Amounts payable after more than one year17€28k€18k▼
Financial debts170/4€28k€18k▼
Amounts payable within one year42/48€51k€262k▲
Current portion of amounts payable after more than one year42€9k€20k▲
Trade debts44€4k€2k▼
Suppliers440/4€4k€2k▼
Taxes, remuneration and social security45€38k€38k▼
Taxes450/3€38k€38k▼
Other amounts payable47/48-€202k
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€12k▼
Other operating charges640/8€927€3k▲
Non-recurring operating charges66A€0-
Gross operating margin9900€171k€154k▼
Operating profit (loss)9901€156k€138k▼
Financial income75/76B€12k€9k▼
Recurring financial income75€12k€9k▼
Financial charges65/66B€3k€4k▲
Recurring financial charges65€3k€4k▲
Profit (loss) for the period before taxes9903€165k€143k▼
Income taxes67/77€38k€34k▼
Profit (loss) for the period9904€128k€110k▼
Profit (loss) for the period to be appropriated9905€128k€110k▼
Appropriation of the result
Profit (loss) to be appropriated9906€128k€110k▼
Transfer from equity791/2-€342k
Transfer to equity691/2€128k€0▼
To other reserves6921€128k€0▼
Profit to be distributed694/7-€452k
Return on contributions (dividend)694-€452k
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
11-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €128k ▲19.9%
Operating result €156k, net result €128k, both a record.
31-12
Financial
Liquidity doublescurrent ratio 7.48
Current ratio from 3.72 to 7.48; short-term debt falls from €73k to €51k.
25-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Weakest financial yearnet €106k ▼1.8%
Net result drops to €106k, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €200kEq €218k ▲95.6%
2 profitable years in a row build equity to €218k.
04-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Goudsbloemstraat 43000 LeuvenGround area
107 m²
Building footprint
88 m²
Volume, LiDAR
698 m³
Parcel 24504E0041/00C000, Flanders · tallest building 13.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Goudsbloemstraat 4, 3000 Leuven
since 20222.330.387.881
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24504E0041/00C000 | Flanders | 107 m² | 1 · 88 m² | 13.3 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Similar companies · same sector, comparable size
Dokter Van Deun Thomas
BE 0721.508.269
Kontich · Eq €3k
DR. CATHERINE THEUWIS
BE 0729.737.037
Alken · Eq €3k
Dr. Tessa Vande Velde
BE 0730.852.438
Heist-op-den-Berg · Eq €3k
DOKTER PHEANDRA DE WACHTER
BE 0730.975.964
Wuustwezel · Eq €3k
Dr. Lara Beunen
BE 0731.743.947
Aarschot · Eq €3k
Of 9,120 companies in sector 86210 we hold annual accounts for 6,336. 1,026 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-02-2022
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.